Home

RHA Urges Congress to Take Action 

RHA writes Congress to protect access for the vulnerable Medicare beneficiaries that rely on life-sustaining dialysis treatments by addressing the detrimental policies in the CY 2023 ESRD PPS final rule and extending the legislative prohibition of including oral-only drugs in the ESRD payment bundle.

Read Letter to Congress

View the latest Voices Discussion Posts

Find tools and resources in our library

Find and network with peers by joining communities

Contact us with your Voices questions

Upcoming Events & Webinars


Announcements

  • Call for Volunteers

    The RHA Quality Committee seeks volunteers to review the RHA QAPI tool and work towards improvements. Applications are due by June 2nd.

  • May 2023 Release: RSE Benchmarking Reports Tool

    ​A comprehensive set of industry financial and clinical/quality benchmarks, including virtually 100% of the dialysis facilities in the U.S., exclusively available to RHA members.

Latest Discussions

  • Profile Picture

    Translation Services

    By: Tyson Aschliman
    Posted in: Voices Community

    Can I get anyone's recommendations on options for "compliant" remote translation services for patients in-center? ... More

  • Profile Picture

    Medical Director FTE

    By: Jayesh Shukla
    Posted in: Voices Community

    Hello, I'm looking for benchmarking or comparative data around Medical Director FTE. If anyone is willing ... More

  • Profile Picture

    RE: USE OF ESA IN ESRD pts who have Myeloma or can ...

    By: Caprice Vanderkolk
    Posted in: Voices Community

    Julie is absolutely correct, I work in both ESRD and Oncology,  Oncology should handle the ESAs as the need is ... More

Resources

No Data Found

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

This Week's Most Active Contributors